Last reviewed · How we verify
NCT05774457
Influence of Virtual Reality on Voice Perception and Production
NA trial testing Voice training in Voice and Voice Disorders in 10 participants. Status unknown.
31 August 2024
Quick facts
| Lead sponsor | University of Delaware |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | sequential |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 10 |
| Start date | 1 April 2024 |
| Primary completion | 31 August 2024 |
| Estimated completion | 31 March 2025 |
Drugs / interventions tested
- Voice training
Conditions studied
- Voice and Voice Disorders — all drugs for Voice and Voice Disorders →
- Virtual Reality — all drugs for Virtual Reality →
Sponsor
University of Delaware
Who can join
Adults 24 to 50, female only, with Voice and Voice Disorders or Virtual Reality. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The specific aim of the clinical trial portion of the larger research project is to obtain preliminary data on the utility of voice training (resonant voice) in the VR environment compared to a traditional clinical environment, using a mixed model within- and between-subjects randomized experimental design. Independent Variables are (1) training and test condition (clinic room vs VR classroom for training); (2) visual speaker-to-listener distance (2m, 4m, and 6m for training); and (3) time point (baseline at 2 m, retention test at 4 m, and 9 m for transfer test). Dependent Variables are (a) vocal sound pressure level (SPL); and (b) spectral moments (spectral mean and standard deviation (in Hz and cents), skewness, and kurtosis). The hypothesis is that a two-way interaction will be shown between training condition and time point showing greater acquisition and transfer of voice skills following training in the VR environment than in the typical clinical environment. This series will utilize a high degree of innovation and sophisticated VR technology to identify parameters important for subsequent VR development in voice therapy, and to lay the empirical foundation for subsequent studies that build on the present work expanding both its basic science and translational value.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05774457
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Voice and Voice Disorders
Currently open trials in the same condition.
- NCT06854380 — Effect of Intralesional Injection of Corticosteroids Combined with Hyaluronidase in Treatment of Minimal Associated Path · EARLY_PHASE1 · recruiting
Other University of Delaware trials
Trials by the same sponsor.
- NCT07420218 — Menopausal Hormones and Sympathetic Activation · Phase 4 · not yet recruiting
- NCT07536217 — Developmental Pilot of Support Groups for Caregivers of Children With DLD · NA · enrolling by invitation
- NCT07054840 — Pain and Split-belt Motor Learning in Older Adults · NA · recruiting
- NCT06916260 — Light Therapy Intervention in Individuals With Parkinson's Disease · NA · recruiting
- NCT07071077 — Examining the Feasibility of Implementing a Hypertension Storytelling Intervention Among African Americans · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05774457 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Delaware
- Last refreshed: 17 March 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05774457.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing